stockrowBio-Rad Laboratories, Inc.
BIO.B Healthcare Medical Devices
Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.
- Revenue
- +0.52%
- EPS
- +234.9%
- Free cash flow
- +8.07%
- Total debt
- +0.11%
Quarter to September 2026, against a year earlier
Follow BIO.B
Alert me
Bio-Rad Laboratories, Inc. (BIO.B) Operating cash flow
Bio-Rad Laboratories, Inc.'s operating cash flow for fiscal 2025 was $532.2M, up 16.9% from $455.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was $468.1M. Over the past ten years it has ranged from $104.1M (fiscal 2017) to $669.5M (fiscal 2021); the current reading is higher than 82% of that period. Operating cash flow has risen for 3 consecutive fiscal years. Bio-Rad Laboratories, Inc. ranks 15th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $532.2M | 16.92% |
| FY2024 | $455.2M | 21.42% |
| FY2023 | $374.9M | 92.85% |
| FY2022 | $194.4M | (70.96%) |
| FY2021 | $669.5M | 14.44% |
| FY2020 | $585.0M | 27.75% |
| FY2019 | $457.9M | 60.39% |
| FY2018 | $285.5M | 174.15% |
| FY2017 | $104.1M | (51.80%) |
| FY2016 | $216.1M | 16.03% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $96.4M | (2.33%) |
| Jun 2026 | $98.7M | (8.70%) |
| Mar 2026 | $108.1M | (34.45%) |
| Dec 2025 | $164.9M | 36.39% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $3.1B |
| GMED Globus Medical, Inc. compare | $925.9M |
| PODD Insulet Corporation compare | $509.0M |
| BIO.B Bio-Rad Laboratories, Inc. | $468.1M |
| BIO Bio-Rad Laboratories, Inc. compare | $468.1M |
| BRKR Bruker Corporation compare | $341.8M |
| PEN Penumbra, Inc. compare | $261.0M |
| TXG 10x Genomics compare | $127.1M |
| GKOS Glaukos Corporation compare | $47.7M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on BIO.B
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement